top of page

Skyhawk News

Skyhawk's proprietary platform revolutionizes disease treatment by developing small molecule therapeutics that modify RNA expression

June 26, 2018

Skyhawk Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing

Skyhawk Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing

Skyhawk and Celgene enter into a five-year strategic collaboration.

January 24, 2018

Skyhawk, copying Dragonfly model, gets cash for RNA R&D

Skyhawk, copying Dragonfly model, gets cash for RNA R&D

Tim Disney—the great-nephew of Walt Disney—is among those who have signed term sheets.

June 26, 2018

Biotech Celgene inks $60M deal with newcomer Skyhawk to develop RNA drugs for ALS, Huntington’s

Biotech Celgene inks $60M deal with newcomer Skyhawk to develop RNA drugs for ALS, Huntington’s

Under the deal, Celgene received the exclusive option to license up to five drug candidates born out of Skyhawk’s development platform

January 2, 2018

Disney, Family Offices Back Second Bio Startup from Tech Entrepreneur Haney

Disney, Family Offices Back Second Bio Startup from Tech Entrepreneur Haney

To launch his first biotech startup, Dragonfly Therapeutics, Bill Haney went to private family offices, including one linked to the...

January 24, 2018

The new serial entrepreneur in the biotech arena launches another upstart looking to drug RNA

The new serial entrepreneur in the biotech arena launches another upstart looking to drug RNA

Af­ter a life­time of en­tre­pre­neur­ship, Bill Haney has dis­cov­ered how much fun it can be to set up new biotechs.

Small Molecules that Modify RNA Expression
Contact

Skyhawk Therapeutics, Inc.
180 3rd Ave., Fifth Floor
Waltham, MA 02451
United States

info@skyhawktx.com
1-617-858-0041

Skyhawk Therapeutics Europe, GmbH
Hochbergerstrasse 60I
Basel 4057 Switzerland
+41 (0) 61 512 15 20

Sitemap
  • X
  • LinkedIn

©2024 Skyhawk Therapeutics - All Rights Reserved

Skyhawk, SkyStar and triangle mark are federally registered trademarks owned by Skyhawk Therapeutics, Inc.

bottom of page